Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2026 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation

HINGHAM, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, commends the American...
March 03, 2026 09:00 ET | Source: Microbot Medical Inc.

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event

HINGHAM, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that the...
February 24, 2026 08:30 ET | Source: Microbot Medical Inc.

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System

Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
February 19, 2026 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference

Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
February 12, 2026 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
February 05, 2026 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

Microbot Medical® to Leverage Current Users Experience of LIBERTY® at Key Oncology Conference to Support Commercial Adoption.
January 12, 2026 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
November 26, 2025 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System

Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
November 05, 2025 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.

Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
October 16, 2025 08:30 ET | Source: Microbot Medical Inc.

Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting

First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY® System Company Completes the Recruitment of its...